Ally Olotu/PLoS One

Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data.Nyandele JP Kibondo UA Issa F Van Geertruyden JP Warimwe G Jongo S Abdulla S Olotu A
PLoS One, (2023). 18:e0291244

Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study.Gitaka J Ogwang C Ngari M Akoo P Olotu A Kerubo C Fegan G Njuguna P Nyakaya G Otieno T Mwambingu G Awuondo K Lowe B Chilengi R Berkley JA
PLoS One, (2017). 12:e0177382

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.Olotu A Clement F Jongert E Vekemans J Njuguna P Ndungu FM Marsh K Leroux-Roels G Bejon P
PLoS One, (2014). 9:e115126

The relationship between RTS,S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection.White MT Bejon P Olotu A Griffin JT Riley EM Kester KE Ockenhouse CF Ghani AC
PLoS One, (2013). 8:e61395

Phenotypic and functional profiling of CD4 T cell compartment in distinct populations of healthy adults with different antigenic exposure.Roetynck S Olotu A Simam J Marsh K Stockinger B Urban B Langhorne J
PLoS One, (2013). 8:e55195

Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.Ibison F Olotu A Muema DM Mwacharo J Ohuma E Kimani D Marsh K Bejon P Ndungu FM
PLoS One, (2012). 7:e52939

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.Ndungu FM Mwacharo J Kimani D Kai O Moris P Jongert E Vekemans J Olotu A Bejon P
PLoS One, (2012). 7:e52870

Estimating individual exposure to malaria using local prevalence of malaria infection in the field.Olotu A Fegan G Wambua J Nyangweso G Ogada E Drakeley C Marsh K Bejon P
PLoS One, (2012). 7:e32929

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.Olotu A Moris P Mwacharo J Vekemans J Kimani D Janssens M Kai O Jongert E Lievens M Leach A Villafana T Savarese B Marsh K Cohen J Bejon P
PLoS One, (2011). 6:e25786

Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites.Bejon P Turner L Lavstsen T Cham G Olotu A Drakeley CJ Lievens M Vekemans J Savarese B Lusingu J von Seidlein L Bull PC Marsh K Theander TG
PLoS One, (2011). 6:e21711

Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya.Olotu A Fegan G Williams TN Sasi P Ogada E Bauni E Wambua J Marsh K Borrmann S Bejon P
PLoS One, (2010). 5:e15569

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.Lusingu J Olotu A Leach A Lievens M Vekemans J Olivier A Benns S Olomi R Msham S Lang T Gould J Hallez K Guerra Y Njuguna P Awuondo KO Malabeja A Abdul O Gesase S Dekker D Malle L Ismael S Mturi N Drakeley CJ Savarese B Villafana T Ballou WR Cohen J Riley EM Lemnge MM Marsh K Bejon P von Seidlein L
PLoS One, (2010). 5:e14090